Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

[Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].

Kálmán J, Kálmán S, Pákáski M.

Neuropsychopharmacol Hung. 2008 Oct;10(4):233-49. Review. Hungarian.

2.
3.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
4.
5.

Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.

Lawlor BA.

J Clin Psychiatry. 2004;65 Suppl 11:5-10. Review.

PMID:
15264965
6.

Pharmacological treatment of non-cognitive disturbances in dementia disorders.

Parnetti L, Amici S, Lanari A, Gallai V.

Mech Ageing Dev. 2001 Nov;122(16):2063-9. Review.

PMID:
11589923
7.
8.

[Behavioural and psychological symptoms of dementia (BPSD): pharmacological management].

Gillabert C, Desmeules J, Vogt-Ferrier N, Dayer P.

Rev Med Suisse. 2006 Apr 12;2(61):970-5. Review. French.

PMID:
16686329
9.

Therapeutic strategies for behavioral and psychological symptoms (BPSD) in demented patients.

Torta R, Badino E, Scalabrino A.

Arch Gerontol Geriatr Suppl. 2004;(9):443-54. Review.

PMID:
15207446
10.

Pharmacological treatment of Alzheimer's Disease.

Bianchetti A, Ranieri P, Margiotta A, Trabucchi M.

Aging Clin Exp Res. 2006 Apr;18(2):158-62. Review.

PMID:
16702787
11.

Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium.

Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B.

Eur Psychiatry. 2005 Nov;20(7):490-6. Epub 2005 Jan 27.

PMID:
16310680
12.
13.

Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.

Ballard C, Corbett A, Chitramohan R, Aarsland D.

Curr Opin Psychiatry. 2009 Nov;22(6):532-40. doi: 10.1097/YCO.0b013e32833111f9. Review.

PMID:
19696673
14.

Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.

Kurz A, Schwalen S S, Schmitt A.

Int Psychogeriatr. 2005 Dec;17(4):605-16. Epub 2005 Sep 27.

PMID:
16185378
15.

Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.

Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L.

Mech Ageing Dev. 2006 Feb;127(2):158-65. Epub 2005 Nov 16. Review.

PMID:
16297434
16.

[Atypical antipsychotics in elderly patients with dementia].

Selbaek G, Engedal K.

Tidsskr Nor Laegeforen. 2008 May 1;128(9):1060-1. Norwegian.

17.

The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.

Beeri MS, Werner P, Davidson M, Noy S.

Int J Geriatr Psychiatry. 2002 May;17(5):403-8.

PMID:
11994927
18.

Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Hemels ME, Lanctôt KL, Iskedjian M, Einarson TR.

Drugs Aging. 2001;18(7):527-50. Review.

PMID:
11482746
19.

A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments.

Ballard CG, Margallo-Lana M, Fossey J, Reichelt K, Myint P, Potkins D, O'Brien J.

J Clin Psychiatry. 2001 Aug;62(8):631-6.

PMID:
11561936
20.

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.

Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Mariën P, Somers N, Nagels G, Pickut BA, De Deyn PP.

Neurochem Int. 2008 May;52(6):1052-60. Epub 2007 Nov 4.

PMID:
18093695
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk